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Abstract
Surgery for radical treatment of esophageal cancer (EC) carries significant inherent
risk. The objective identification of patients who are at high risk of complications is
of importance. In this study the prognostic value of cardiopulmonary fitness vari-
ables (CPF) derived from cardiopulmonary exercise testing (CPET) was assessed in
patients undergoing potentially curative surgery for EC within an enhanced recov-
ery program. OC patients underwent preoperative CPET using automated breath-
by-breath respiratory gas analysis, with measurements taken during a ramped exer-
cise test on a bicycle. The prognostic value of _VO2Peak, Anaerobic Threshold (AT)
and VE/VCO2 derived from CPET were studied in relation to post-operative mor-
bidity, which was collected prospectively, and overall survival. Consecutive 120
patients were included for analysis (median age 65 years, 100 male, 75 neoadjuvant
therapy). Median AT in the cohort developing major morbidity (Clavien–Dindo
classification >2) was 10.4 mL/kg/min compared with 11.3 mL/kg/min with no
major morbidity (P = 0.048). Median _VO2Peak in the cohort developing major
morbidity was 17.0 mL/kg/min compared with 18.7 mL/kg/min in the cohort
(P = 0.009). _VO2Peak optimum cut-off was 17.0 mL/kg/min (sensitivity 70%, speci-
ficity 53%) and for AT was 10.5 mL/kg/min (sensitivity 60%, specificity 44%). Mul-
tivariable analysis revealed _VO2Peak to be the only independent factor to predict
major morbidity (OR 0.85, 95% CI 0.75–0.97, P = 0.018). Cumulative survival was
associated with operative morbidity severity (v2 = 4.892, df = 1, P = 0.027). These
results indicate that _VO2Peak as derived from CPET is a significant predictor of
major morbidity after oesophagectomy highlighting the physiological importance of
cardiopulmonary fitness.
Introduction
Oesophagectomy remains the primary therapeutic modal-
ity for radical and potentially curative treatment for
patients with esophageal cancer (EC), but despite recent
advances in anesthesiology and critical care, it continues
to carry significant inherent risk. Indeed, the 2016 UK
National Oesophago-Gastric Cancer Audit (National
Oesophago-Gastric Cancer Audit, 2018) reported postop-
erative morbidity and mortality of 50% and 1.6%
respectively.
Comprehensive and accurate risk profile assessment
encompassing preoperative modifiable factors and aerobic
capacity should be fundamental within the decision-mak-
ing process for the multidisciplinary team, and patient,
when selecting the most appropriate management modal-
ity, particularly in patients who are elderly and with
comorbidities. Moreover, such a strategy permits patient
optimization prior to surgery and efficient utilization of
critical care resources. Current approaches to risk predic-
tion comprise: clinical acumen, objective scoring systems
such as the Portsmouth Physiological and Operative
Severity Score for the Enumeration of Mortality and Mor-
bidity (P-POSSUM) (Whiteley et al. 1996), Oesopha-
gogastric POSSUM (O-POSSUM) (Tekkis et al. 2004),
American Society of Anesthesiologists (ASA) physical
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status, Charleston Comorbidity Index, plasma biomarkers,
measures of cardiac function (Moyes et al. 2013) and
shuttle walk tests (Murray et al. 2007). Their effectiveness
in predicting surgical morbidity is relatively weak and
measures to improve this process are needed.
Cardiopulmonary exercise testing (CPET) is a dynamic
and noninvasive procedure, which allows approximation
of an individual’s cardiopulmonary fitness to be mea-
sured. This results in an objective assessment of ability to
cope with the metabolic demands associated with the
physiological trauma of major surgery (Smith et al. 2009).
CPET, in particular an anaerobic threshold <11 mL/kg/
min, has been shown to predict post-operative morbidity
and mortality in patients undergoing major abdominal
surgery (Older et al. 1993; Snowden et al. 2013; Moran
et al. 2016). Although CPET is well established in cardio-
thoracic surgery (American Thoracic Society and Ameri-
can College of Chest Physicians, 2003), the number of
studies assessing the value of CPET related to oesophagec-
tomy is few Moran et al. 2016, and none have assessed its
value within the framework of an enhanced recovery pro-
gram (ERP). Enhanced recovery programs, long embed-
ded with gastrointestinal cancer surgical practice, have
been associated with reduced postoperative morbidity and
shortened duration of hospital stay (Fearon et al. 2005;
Karran et al. 2016). The primary aim of this study was to
define the baseline cardiopulmonary fitness levels of
patients undergoing radical surgical treatment in an ERP
and to establish critical threshold values that identify
patients at increased risk of developing major postopera-
tive morbidity as stratified by the Clavien–Dindo Classifi-
cation (Dindo et al. 2004). Clavien–Dindo classification is
an ordinal measure of the severity of postoperative mor-
bidity, which is reproducible and applies to all patients
undergoing surgical procedures. The hypothesis was that
cardiopulmonary fitness, namely _VO2Peak and anaerobic
threshold (AT), would be inversely associated with major
postoperative morbidity in patients undergoing
oesophagectomy. The setting was a regional Upper Gas-
trointestinal cancer network multidiciplinary team (MDT)
serving a population of 1.8 million.
Methods
Study approval
The sponsor of this study was C&V UHB General Surgery
Directorate who deemed it to be in keeping with audit and
service evaluation. Audit and service evaluation is part of
quality assurance. These involve minimal additional risk,
burden or intrusion for participants, are regulated outside
of the Research Ethics system, and do not require approval
from the NHS Research and Development offices. This
opinion was confirmed and approved by Health and Care
Research Wales Research Ethics Service.
Study design
Consecutive patients diagnosed with esophageal (includ-
ing oesophagogastric junctional type 1 and 2) cancer of
any cell type, between August 2010 and August 2016,
considered for surgical treatment by an MDT were identi-
fied and referred for prospective CPET testing. Patients
undergoing total gastrectomy for junctional type 3 cancers
and palliative procedures were excluded.
Patients
Data relating to the preoperative status, operative procedure
and outcome were collected prospectively. The preoperative
assessment process was defined as the process from diagno-
sis to the time of anesthesia for definitive surgery. This per-
iod also included the completion of the radiological staging
process. Data which were collected included age, gender,
American Association of Anesthesiology (ASA) grade, radio-
logical and histopathological stage of disease (TNM7) (Sobin
et al. 2009), cancer site, operative mortality (defined in this
study as 30 day or inpatient death on index admission),
operative morbidity graded in accordance with the Clavien–
Dindo Classification (CDC) (Dindo et al. 2004), duration or
length of hospital stay (LOHS), and survival from date of
diagnosis.
Surgical treatment and neoadjuvant
therapy
All patients had management plans individually tailored
according to factors relating to both the patient and their
disease. Staging was by means of computed tomography,
endoscopic ultrasound, computed tomography positron
emission tomography (CT PET) and staging laparoscopy
as appropriate. The South East Wales MDT treatment
algorithms for EC have been described previously (Mor-
gan et al. 2009). The standard operation consisted of
subtotal transthoracic oesophagectomy (TTO) as
described by Lewis (1946) and Tanner (1947). Transhiatal
oesophagectomy (THO), as described by Orringer (1985),
was used selectively in patients with adenocarcinoma of
the lower third of the esophagus who had significant car-
diorespiratory comorbidity, T1/2 N0 or T3 N0 disease.
All procedures were performed using an open approach.
CPET testing
The CPET followed American Thoracic Society/American
College of Chest Physicians recommendations (American
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Thoracic Society and American College of Chest Physi-
cians, 2003), and performed prior to any treatment com-
mencing. All patients performed a symptom limited
CPET conducted on an electromagnetically braked cycle
ergometer, and comprised a 2–3 min rest phase (to allow
gas exchange variables to stabilize), 3 min unloaded
cycling, then a ramped incremental protocol until voli-
tional termination, and a 2–min recovery period. Ventila-
tion and gas exchange was measured with a Medgraphics
UltimaTM metabolic cart (Medical Graphics, St Paul,
Minnesota) with BreezesuiteTM and Welch Allyn (Welch
Allyn, Inc., NY) software. Metabolic data were collected
breath-by-breath through a mouthpiece with saliva trap
using mid five of seven breath averaging. Resting spirom-
etry was performed prior to each exercise test (Rose et al.
2018; Rose et al. 2018).
Heart rate, full 12-lead electrocardiogram, blood pres-
sure and pulse oximetry were monitored throughout. The
ramp gradient was set to 10–20 Watts based on the pre-
dicted _VO2Peak from the age, weight, height and sex of
the patient in order to produce an exercise test of
between 8–12 min duration (Wasserman, 2012). Prior to
each test, the CPET equipment was calibrated against ref-
erence gases. The AT was determined using the V-slope
method and confirmed by changes in ventilatory effi-
ciency for oxygen (VE/V02) and end-tidal partial pressure
values for oxygen (PETO2) (Wasserman, 2012). AT was
validated independently by two experienced clinicians (IA
and RD). _VO2Peak was the highest _VO2 achieved during
the final 30 sec of the test. The VE/VCO2 slope was mea-
sured at the AT. Test termination criteria included:
request of patient, volitional fatigue, chest or leg pain, or
electrocardiographic abnormalities determined by the
consultant anesthetist.
Enhanced recovery program
An ERP was integral to the surgical model based on the
principles introduced by Basse and colleagues (Basse et al.
2000). Multimodal programs (transthoracic and transhi-
atal) were developed following an information gathering
process inclusive of surgical, oncological, radiological, die-
tetic, nursing, and physiotherapy staff, including a litera-
ture review to inform specific pathway aspects (Karran
et al. 2014). Pathway booklets were created, which served
as a unified multidisciplinary patient record, within which
all documentation was centralized. The standardized anes-
thetics approach comprised a thoracic epidural followed
by a general anesthetic. Arterial and central venous lines
were used in all patients and goal directed fluid therapy
was utilized with the aid of lithium dilution cardiac out-
put monitoring (LiDCO Ltd. Copyright © LiDCO 2015.
Company registered in England No. 2659005).
Outcome measures
Primary outcome measures were major operative morbid-
ity, related to CDC severity grade (Dindo et al. 2004), 30-
day operative mortality, and cumulative overall survival
in months from date of diagnosis. Particular emphasis
was placed on the incidence of morbidity of CDC grade
III or higher, as this represented a complication requiring
endoscopic, radiological or surgical intervention. A sec-
ondary outcome measure was duration or length of hos-
pital stay (LOHS) in days. No patients were lost to
follow-up, and dates and causes of death were obtained
by the Wales Cancer Intelligence and Surveillance Unit,
from the Office of National Statistics. Patients were fol-
lowed-up at 3-monthly intervals for the first year, then 6-
monthly for the second year and then annually thereafter
for a minimum of 5 years or death. Patients underwent
clinical and blood evaluation, including Carcino Embry-
onic Antigen (CEA) measurement, at each clinic appoint-
ment. Patients who presented with symptoms suggestive
of recurrent disease underwent a CT scan of the thorax,
abdomen and pelvis, supplemented with endoscopic eval-
uation if indicated. The proportion of patients followed-
up for 1, 3 and 5 years was 108 (90.0%), 71 (59.2%) and
42 (35.0%) respectively.
Statistical analysis
Statistical analysis was performed using SPSS (IBM
SPSS Statistics v20.0.0.2, IBM Corporation, Armonk,
New York). Shapiro–Wilk tests were used to assess distri-
bution normality. Grouped data were expressed as med-
ian (range) and nonparametric analyses were used
throughout. Results were considered to be statistically sig-
nificant at the 5% level. Categorical data were compared
using the chi-squared test, except where groups contained
counts of fewer than five, when Fisher’s exact test was
used. Grouped continuous data were compared using the
Mann–Whitney U-test. Non-parametric Receiver Opera-
tor Characteristic (ROC) curves were used for the predic-
tive value of CPET variables (Youden, 1950). Logistic
regression was used to determine the association of CPET
variables with morbidity. Variables associated with major
morbidity on univariable analysis at the P < 0.10 level
were entered into a multivariate binary logistic regression
analysis, using a forward conditional stepwise method.
LOHS and survival analyses were conducted using the
conventional method described by Kaplan and Meier.
Results
During the study period, 180 patients underwent CPET.
Of these, 60 patients did not proceed to resection and
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were excluded from further analysis (23 deemed unfit, 25
had cancer stage progression, and 12 had open and close
procedures). Therefore, 120 patients (100 males, 20
females) were included in the analysis. There were no dif-
ferences in age (P = 0.893), gender (P = 0.926), or ASA
grade (P = 0.463), between the no major morbidity and
major morbidity cohorts. More THOs were performed
(76, 63.3%) compared with TTO procedures (44, 36.7%).
Major morbidity was similar after both operative
approaches (THO 25.0% vs. TTO 27.3%, P = 0.784)
(Table 1). Seventy-five patients received neoadjuvant ther-
apy as part of the NEOSCOPE trial (Mukherjee et al.
2015): 60 receiving chemotherapy and 15 chemoradio-
therapy.
Major morbidity
Seventy-seven patients (64.2%) developed postoperative
morbidity of any CDC grade and 31 patients (25.8%)
experienced major morbidity (CDC grade ≥ III). The
major morbidity included: 12 patients (10.0%) who
developed an anastomotic leak with seven requiring oper-
ative intervention; 11 (9.2%) developed significant respi-
ratory complications (1 ARDS, 2 pneumothorax, eight
chest sepsis), 2 (1.6%) developed chyle leaks (both man-
aged operatively), 2 (1.6%) developed postoperative
bleeding requiring operative intervention, 2 (1.6%) devel-
oped small bowel ischemia, one developed multi organ
failure, and one patient developed a bile leak following
pyloroplasty. Of the 31 patients developing major mor-
bidity, 20 (64.5%) received neoadjuvant therapy (16
chemotherapy and four chemoradiotherapy) and 11
(35.5%) underwent surgery alone, P = 0.788 (Table 1).
There were four deaths (3.3%) within 30 days of surgery
and the causes of death were: anastomotic leak (two
patients), Acute Respiratory Distress Syndrome (1), and
secondary intrathoracic hemorrhage (1).
Four patients had indeterminate AT (three respiratory
exchange ratio (RER) >1, and one patient was unable to
complete the test); all developed major morbidity
(Table 3). For the complete cohort the baseline median
AT was 11.0 mL/kg/min (range 7.0–22.3), median
_VO2Peak was 18.2 mL/kg/min (range 10.9–38.76), and
median VO/VCO2 was 30.0 (range 13.3–44.0).
Table 2 shows cardiopulmonary fitness variables related
to operative approach. Nonparametric ROC curves illus-
trated that both _VO2Peak and AT were associated with
major morbidity (Fig. 1). For _VO2Peak (area under the
curve 0.66, 95% CI 0.55–0.77, P = 0.009), the optimal
cut-off point was 17.0 mL/kg/min, giving sensitivity of
70% and specificity of 53%.
For AT (area under the curve 0.62, 95% CI 0.51–0.74,
P = 0.048) the optimal cut-off point was 10.5 mL per kg
per min, giving sensitivity of 60% and specificity of 44%.
Patients with a _VO2Peak lower than 17.0 mL/kg/min were
twice as likely to develop major morbidity than patients
with a higher _VO2Peak, 38.6% versus 18.4% respectively,
P = 0.015. Patients with AT lower than 10.5 mL/kg/min
were twice as likely to develop major morbidity than
patients with higher AT, 35% versus 18% respectively,
P = 0.034. Multivariable analysis, Table 3, revealed
_VO2Peak to be the only factor independently associated
with morbidity of CDC grade ≥ III (OR 0.85, 95% CI
0.75–0.97, P = 0.018).
Duration of hospital stay
The overall median duration or length (LOHS) for all
patients was 16 (9–153) days. Patients categorized with
morbidity severity scores of CDC grade 0, I and II had
a median LOHS of 15 (10–49) days, compared with a
LOHS of 35 (9–153) days in patients categorized with
morbidity severity scores of CDC grade ≥ III
(P < 0.001). The LOHS was, on average, one day
shorter in patients with _VO2Peak values above the cut-
off value than patients below the cut-off value, median
16 (9–106) versus 15 (9–153) days, P = 0.040. No dif-
ference in LOHS was observed when dichotomized
above and below the AT cut-off value of 10.5 mL/kg/
min, with both cohorts’ LOHS equating to 16 days,
P = 0.273.
Survival
The overall median cumulative survival for all patients
was 64 (4–85) months. There were 44 deaths, of which
four were postoperative deaths, and were included in
the survival analysis. The 1-, 3- and 5-year overall sur-
vival rates were 93.51%, 64.78% and 54.76% respec-
tively. Overall survival was not associated with any
CPET variables (supplementary Table S1). Not receiving
neoadjuvant therapy (P = 0.012), higher radiological (r)
T stage (P = 0.001), rN stage (P = 0.006), higher patho-
logical (p) T stage (P < 0.001), pN stage (P < 0.001),
circumferential resection margin positivity (P < 0.001),
and high CDC grade (P = 0.031, Fig. 2), were associ-
ated with poor overall cumulative survival. On multi-
variable analysis higher rN stage (HR 1.47 95% CI
1.02–2.13, P = 0.041), pN stage (HR 1.61 95% CI 1.14–
2.26, P = 0.006), CRM positivity (HR 2.57 95% CI
1.27–5.19, P = 0.008), and CDC morbidity (HR 2.60
95% CI 1.32–5.14, P = 0.006), were independently asso-
ciated with poor overall cumulative survival (supple-
mentary Table S1). OM 1-, 3- and 5-year survival was
81.5%, 62.5% and 42.9% versus 97.5%, 70.7% and
62.5% for the cohort without OM.
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Discussion
This study represents the largest contemporary report
regarding the value of CPET in the risk profile assessment
of consecutive patients diagnosed with EC, and suitable
for potentially curative radical multimodal ERP enhanced
treatment, in a regional high volume Upper Gastro
Intestinal (UGI) cancer network. The principal findings
were that CPET was an objective risk assessment tool
before oesophagectomy, and the best prognostic markers
of major postoperative morbidity were AT (optimal cut-
off 10.5 mL per kg per min), and _VO2Peak (optimal cut-
Table 1. Patient demographics, combined radiological and histopathological stage related to Clavien–Dindo grade ≥3 morbidity.
Total No Major Morbidity Major Morbidity
P-valuen = 120 n = 89 n = 31
Age (years)1 65 (38–84) 65 (42–84) 65 (38–75) 0.893
Gender (M:F) 100:20 74:15 26:5 0.926
ASA grade 0.463
I 9 (7.5) 8 (8.9) 1 (3.2)
II 72 (60.0) 54 (60.6) 18 (58.1)
III 39 (32.5) 27 (30.3) 12 (38.7)
CPET variables
AT (mL/kg/min) 11.0 (7.0–22.3) 11.3 (7.0–22.3) 10.4 (7.6–15.9) 0.048
_VO2Peak (mL/kg/min) 18.2 (10.9–38.9) 18.7 (11.3–38.8) 16.9 (10.9–26.2) 0.009
VE/VCO2 30.0 (13.3–44.1) 30.0 (21.5–44.1) 32.0 (13.3–39.2) 0.584
Neoadjuvant therapy 0.964
None 45 (37.5) 34 (38.2) 11 (35.5)
Chemotherapy 60 (50.0) 44 (49.4) 16 (51.6)
Chemo radiotherapy 15 (12.5) 11 (12.4) 4 (12.9)
Surgery 0.784
Transthoracic 44 (36.7) 32 (36.0) 12 (38.7)
Transhiatal 76 (63.3) 57 (64.0) 19 (61.3)
Radiological T Stage 0.870
Tx 4 (3.3) 3 (3.4) 1 (3.3)
T1 21 (17.5) 15 (16.9) 6 (19.4)
T2 17 (14.2) 14 (15.7) 3 (9.7)
T3 70 (58.3) 52 (58.4) 18 (58.1)
T4 8 (6.7) 5 (5.6) 4 (9.7)
Radiological N Stage 0.962
N0 75 (62.5) 56 (62.9) 19 (61.3)
N1 32 (26.7) 24 (27.0) 8 (25.8)
N2 9 (7.5) 6 (6.7) 3 (9.7)
N3 4 (3.3) 3 (3.4) 1 (3.3)
Pathological T Stage 0.005
HGD2 5 (4.2) 2 (2.2) 3 (9.7)
T1 28 (23.3) 26 (29.2) 2 (6.5)
T2 19 (15.8) 12 (13.5) 7 (22.6)
T3 62 (51.7) 47 (52.8) 15 (48.4)
T4 6 (5.0) 2 (2.2) 4 (12.9)
Pathological N Stage 0.088
N0 58 (48.3) 46 (51.7) 12 (38.7)
N1 32 (26.7) 19 (21.3) 13 (41.9)
N2 24 (20.0) 18 (20.2) 6 (19.4)
N3 6 (5.0) 6 (6.7) 0 (0.0)
Resection Margin 0.740
R03 65 (54.2) 49 (55.1) 16 (51.6)
R1 55 (45.8) 40 (44.9) 15 (48.4)
Values in parentheses are percentages; 1Values are median (range); AT, anaerobic threshold; _VO2Peak, oxygen uptake at peak exercise; VE/
VCO2, minute ventilation;
2High Grade Dysplasia; 3R0, Resection margin clear; R1 resection margin involved (microscopic circumferential resec-
tion margin positive).
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off of 17.0 mL per kg per min), similar to values reported
and related to major abdominal surgery (Older et al.
1993; Older et al. 1999), pancreatic (Ausania et al. 2012;
Chandrabalan et al. 2013), colorectal (West et al. 2014;
West et al. 2014) and bariatric surgery (Moran et al.
2016). Patients with poorer _VO2Peak and AT values below
these critical levels were over twice as likely to develop
major morbidity than patients with values above the criti-
cal levels, and _VO2Peak was independently associated with
postoperative major morbidity, which consequently had
an adverse influence on long-term survival which was 1.5
times better in the absence of major operative morbidity
(OM 5-year survival 97.5% vs. 62.5% for cohort without
OM).
This study extends literature supporting objective mea-
sures of physical fitness derived by CPET for risk assess-
ment in major abdomino-thoracic surgery (Ross et al.
2016). Nagamatsu et al from Kitakyushu City, Japan,
reported that cardiopulmonary complications were associ-
ated with maximum oxygen uptake for patients having
oesophagectomy with a three-field lymphadenectomy,
with surgery performed safely on patients with a maxi-
mum oxygen uptake of at least 800 mL per min per m2
(Nagamatsu et al. 2001). Forshaw et al from St Thomas’
hospital, London, England, reported _VO2Peak to be signifi-
cantly poorer in patients developing cardiopulmonary
complications after oesophagectomy (19.2 mL/min/kg in
the complication cohort and 21.4 mL/min/kg in the no
complication cohort), allied with a trend towards poorer
ATs, and concluded that CPET was of limited value in
predicting postoperative cardiopulmonary morbidity
(Forshaw et al. 2008). However, these reports described
cardiopulmonary complications alone, observed after sur-
gery performed outside the framework of an ERP, in con-
trast to all major morbidity (graded by severity) within
an established ERP. Whether single variable endpoints
derived from CPET are associated with cumulative sur-
vival remains uncertain, but in the present study, all of
the patients who died within one year of surgery, seven
(5.8%) had a _VO2Peak of <21.2 mL per kg per min, and
developed postoperative in-hospital morbidity, which may
arguably represent an endpoint related to survival in such
patient cohorts.
No differences were observed in preoperative physical
fitness or postoperative morbidity between patients
receiving neoadjuvant chemotherapy or chemoradiother-
apy, when compared with patients proceeding to surgery
alone. Recently, it has been reported that preoperative
chemotherapy may cause physical deconditioning and
impair cardiopulmonary function (Jack et al. 2014; Sin-
clair et al. 2016). Neither the impact of neoadjuvant
chemotherapy or chemoradiotherapy on postoperative
morbidity, nor the benefits of improving preoperative
Table 2. Cardiopulmonary exercise variables related to operative
approach.
Variable THO TTO P-value
AT (mL/min/kg) 10.7 (7.0–22.3) 11.9 (7.0–16.8) 0.188
_VO2Peak (mL/min/kg) 17.9 (11.9–38.8) 18.4 (10.9–25.9) 0.219
VE/VCO2 30.0 (13.3–44.0) 30.0 (23.0–40.0) 0.771
Numbers are median (range).
Figure 1. Cardiopulmonary fitness variable ROC curves.
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fitness by means of exercise interventions have yet to be
established.
The strengths of this study include the consecutive nat-
ure of patient assessment for eligibility, the homogeneous
study population, the use of the Clavien–Dindo morbidity
severity score, the clinical management by an established
and experienced multidisciplinary team whose results are
well audited and stand up to international comparison
(Karran et al. 2016), and the fact that all patients received
the benefit of an ERP (Karran et al. 2016). Moreover, the
survival data is particularly robust as none of the patients
were lost to follow-up. Potential limitations include the
single center design, which limits the generalizability of
the data, as well as the ROC curve critical levels that were
optimized and derived for this local patient cohort as part
of service evaluation. The numbers of patients in this
contemporary cohort is modest and the possibility exists
that critical CPET values for some outcomes have failed
to emerge because of the possible influence of selection
bias, type II statistical error, or both. Moreover, AT has
been shown to be subject to biological and analytical vari-
ation which may influence threshold values for clinical
decision making (Davison et al. 2012). The number of
operative deaths, four, is also too few to draw any mean-
ingful conclusion on the influence of CPET variables on
mortality prediction. The median ATs observed in all
levels of morbidity severity was lower than that reported
widely in the literature and associated with poor physical
fitness, although no internationally agreed critical cut-off
value for AT exists. This implies that patient selection for
surgery was not influenced solely by this variable. Such
poor physiological fitness may arguably be due to multi-
ple factors such as; deprivation, malnutrition, and
advanced stage of disease. Clearly this was not a random-
ized controlled trial and so no comparison group exists
to compare the impact of CPET on patient outcomes.
Clinical implications
Mostly, AT has been regarded as the principal exercise
variable for identifying high-risk patients undergoing sur-
gery. Similar to Forshaw et al, this study found _VO2Peak
to be a statistically stronger predictor for major morbidity
when compared with AT. Due to the difference in prog-
nostic significance between these two exercise variables
future research should focus on developing a composite
score, encompassing multiple CPET variables, particularly
_VO2Peak, to assess the risk profiles of a cohort of patients,
considered to have significant comorbidity, and who may
not have the physiological reserve to withstand complex
major esophageal surgery with its inherent major associ-
ated pre-, peri-, and post-operative challenges. In clinical
Table 3. Univariable and multivariable analysis of preoperative factors associated with major morbidity.
Univariable
P-value
Multivariable
P-valueOdds ratio (95% CI) Odds ratio (95% CI)
Age (years)(<65/66–75/>75) 0.87 (0.34–2.19) 0.761
Gender(Male/Female) 1.65 (0.46–5.89) 0.441
ASA(I/II/III) 1.10 (0.47–2.55) 0.827
Operative approach(Transhiatal/Transthoracic) 0.89 (0.53–1.49) 0.648
Neoadjuvant therapy(Yes/No) 0.78 (0.22–2.77) 0.695
Radiological T stage(X/1/2/3/4) 0.91 (0.49–1.72) 0.775
Radiological N stage(0/1/2/3) 1.00 (0.51–2.00) 0.991
AT (mL/kg/min) 0.81 (0.66–1.00) 0.053 0.537
_VO2Peak (mL/kg/min) 0.85 (0.75–0.97) 0.014 0.85 (0.75–0.97) 0.018
VE/VCO2 0.98 (0.88–1.08) 0.640
Figure 2. Cumulative overall survival related to major morbidity
after oesophagectomy.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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practice a composite score may become an adjunct in the
decision-making process to determine the most effica-
cious modality of treatment between the clinician and
patient. Finally, focused work is desirable regarding the
potential impact of preoperative targeted exercise training
programs, to improve and maximize patients’ CPET per-
formance before oesophagectomy.
In conclusion, _VO2Peak was shown to be an important
prognostic indicator of major morbidity after oesophagec-
tomy. Cumulative survival was associated with the mor-
bidity severity score, but not with CPET variables, though
further follow-up would be desirable in this regard. CPET
therefore, has an important role in refining decisions
regarding the optimum tailored treatment modality for
patients diagnosed with EC, and also in planning appro-
priate postoperative care. Yet, clinical access to CPET
remains limited, with the most recent literature reporting
that only 32% of English hospitals have ready access to
this utility (Huddart et al. 2013).
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